Compass Therapeutics Inc (NASDAQ: CMPX) started the day on Wednesday, with a price increase of 8.03% at $3.9, before settling in for the price of $3.61 at the close. Taking a more long-term approach, CMPX posted a 52-week range of $1.27-$4.08.
In the past 5-years timespan, the Healthcare sector firm’s annual sales growth was -104.70%. Meanwhile, its Annual Earning per share during the time was -104.70%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -50.17%. This publicly-traded company’s shares outstanding now amounts to $138.28 million, simultaneously with a float of $109.99 million. The organization now has a market capitalization sitting at $669.14 million. At the time of writing, stock’s 50-day Moving Average stood at $3.30, while the 200-day Moving Average is $2.61.
Compass Therapeutics Inc (CMPX) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. Compass Therapeutics Inc’s current insider ownership accounts for 35.89%, in contrast to 43.14% institutional ownership. According to the most recent insider trade that took place on May 27 ’25, this organization’s CHIEF EXECUTIVE OFFICER bought 10,000 shares at the rate of 2.11, making the entire transaction reach 21,100 in total value, affecting insider ownership by 6,480,825. Preceding that transaction, on Apr 09 ’25, Company’s Director sold 3,571,428 for 1.59, making the whole transaction’s value amount to 5,678,571. This particular insider is now the holder of 0 in total.
Compass Therapeutics Inc (CMPX) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.13 per share during the current fiscal year.
Compass Therapeutics Inc’s EPS decrease for this current 12-month fiscal period is -50.17% and is forecasted to reach -0.55 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will decrease by -8.92% through the next 5 years, which can be compared against the -104.70% growth it accomplished over the previous five years trading on the market.
Compass Therapeutics Inc (NASDAQ: CMPX) Trading Performance Indicators
Let’s observe the current performance indicators for Compass Therapeutics Inc (CMPX). It’s Quick Ratio in the last reported quarter now stands at 7.66.
In the same vein, CMPX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.45, a figure that is expected to reach -0.14 in the next quarter, and analysts are predicting that it will be -0.55 at the market close of one year from today.
Technical Analysis of Compass Therapeutics Inc (CMPX)
If we take a close look at the recent performances of Compass Therapeutics Inc (NASDAQ: CMPX), its last 5-days Average volume was 1.73 million that shows progress from its year to date volume of 1.42 million. During the previous 9 days, stock’s Stochastic %D was recorded 74.04% While, its Average True Range was 64.08.
Raw Stochastic average of Compass Therapeutics Inc (CMPX) in the period of the previous 100 days is set at 98.70%, which indicates a major rise in contrast to 96.12% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.25 that was higher than 0.20 volatility it exhibited in the past 100-days period.
